Relafen 750, chemically known as naproxen sodium , represents a fascinating illustration within the biochemical area of pain alleviation. Its mechanism of action involves the selective inhibition of cyclooxygenase-2 (COX-2), an enzyme critical for the synthesis of prostaglandins . Unlike non-sele

From a molecular pharmacy perspective , Relafen 750 ( the drug) represents a compelling case study. Its mechanism of inhibiting cyclooxygenase enzymes, particularly the enzyme subtype, highlights the complexities of pain control. The medication's medicinal effect stems from alleviating prostaglan